Konvomep Kit
Product Images NDC 65628-272

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Konvomep (NDC 65628-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Omeprazole Structure (Image 01)

Omeprazole Structure (Image 01)
Chemical structure of omeprazole, the active ingredient in Konvomep kit by Azurity Pharmaceuticals, Inc.*
FDA Label Image

Sodium Bicarbonate Structure (Image 02)

Sodium Bicarbonate Structure (Image 02)
Chemical structure of sodium bicarbonate showing the sodium ion bonded to the bicarbonate ion with hydroxyl and carbonyl groups.*
FDA Label Image

Principal Display Panel (Diluent Label)

Principal Display Panel (Diluent Label)
Diluent for reconstitution of Konvomep (omeprazole and sodium bicarbonate) oral suspension kit by Azurity Pharmaceuticals, Inc. The label details sodium bicarbonate 84 mg/mL, total 25.2 g in 300 mL, strawberry flavor, storage at 2° to 8°C, and pharmacist instructions for use with omeprazole powder. Includes barcode and NDC 65628-271-10.*
FDA Label Image

Principal Display Panel (Konvomep Label)

Principal Display Panel (Konvomep Label)
Konvomep oral suspension kit containing omeprazole and sodium bicarbonate in a 2 mg/84 mg per mL concentration. The label includes dispensing instructions, pharmacist reconstitution notes, storage conditions, and manufacturer information for Azurity Pharmaceuticals, Inc. The label also shows the NDC 65628-270-10 and barcode.*
FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
Konvomep kit label for oral suspension containing omeprazole and sodium bicarbonate at 2 mg/84 mg per mL. The label shows instructions to pharmacists, storage requirements, and contents including strawberry-flavored diluent. Azurity Pharmaceuticals, Inc. is the labeler, and the package includes preparation, usage guidance, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.